Companion Animal Specialty Drugs Market 2027 By Product Type, Distribution Channel | The Insight Partners

Companion Animal Specialty Drugs Market to 2027 - Global Analysis and Forecasts by Product Type (Antibiotics Segment, Anti-inflammatory Products Segment, Parasiticides, Heartworm, Behavioral Products, Nutritional Products, Skin Care Products, Vaccines Product); Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores)

Report Code: TIPRE00005684 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Companion Animal are primarily kept as a company for entertainment and safety. Some common companion animals are dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice and amphibians.

MARKET DYNAMICS
The Companion Animal Specialty Drugs market is anticipated to grow in the forecast, owing to the factors such as increasing adoption of companion animals, increasing numbers of nuclear families and increase in number of diseases infecting the companion animals, increase in pet humanization and enhanced product offerings. Nevertheless, patent expiries of approved drugs and inability to understand behavioral symptoms are expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Companion Animal Specialty Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Companion Animal Specialty Drugs market with detailed market segmentation by product type, distribution channel and geography. The global Companion Animal Specialty Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Companion Animal Specialty Drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Companion Animal Specialty Drugs market is segmented on the basis of product type and distribution channel. Based on product type the market is segmented into Antibiotics Segment, Anti-inflammatory Products Segment, Parasiticides, Heartworm, Behavioral Products, Nutritional Products, Skin Care Products, Vaccines Product. Based on distribution channel the market is segmented into Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Companion Animal Specialty Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Companion Animal Specialty Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Companion Animal Specialty Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Companion Animal Specialty Drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the Companion Animal Specialty Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Companion Animal Specialty Drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Companion Animal Specialty Drugs market in the global market. Below mentioned is the list of few companies engaged in the Companion Animal Specialty Drugs market.

The report also includes the profiles of Companion Animal Specialty Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Bayer AG
  • Intervet Inc
  • Zoetis
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Aratana Therapeutics, Inc.
  • Beaphar
  • Virbac
  • Ceva
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Companion Animal Specialty Drugs Market - By Product Type
1.3.2 Companion Animal Specialty Drugs Market - By Distribution Channel
1.3.3 Companion Animal Specialty Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COMPANION ANIMAL SPECIALTY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COMPANION ANIMAL SPECIALTY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COMPANION ANIMAL SPECIALTY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. COMPANION ANIMAL SPECIALTY DRUGS - GLOBAL MARKET OVERVIEW
6.2. COMPANION ANIMAL SPECIALTY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. COMPANION ANIMAL SPECIALTY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIBIOTICS SEGMENT
7.3.1. Overview
7.3.2. Antibiotics Segment Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY PRODUCTS SEGMENT
7.4.1. Overview
7.4.2. Anti-inflammatory Products Segment Market Forecast and Analysis
7.5. PARASITICIDES
7.5.1. Overview
7.5.2. Parasiticides Market Forecast and Analysis
7.6. HEARTWORM
7.6.1. Overview
7.6.2. Heartworm Market Forecast and Analysis
7.7. BEHAVIORAL PRODUCTS
7.7.1. Overview
7.7.2. Behavioral Products Market Forecast and Analysis
7.8. NUTRITIONAL PRODUCTS
7.8.1. Overview
7.8.2. Nutritional Products Market Forecast and Analysis
7.9. SKIN CARE PRODUCTS
7.9.1. Overview
7.9.2. Skin Care Products Market Forecast and Analysis
7.10. VACCINES PRODUC
7.10.1. Overview
7.10.2. Vaccines Produc Market Forecast and Analysis
8. COMPANION ANIMAL SPECIALTY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. VETERINARY HOSPITALS
8.3.1. Overview
8.3.2. Veterinary Hospitals Market Forecast and Analysis
8.4. VETERINARY CLINICS
8.4.1. Overview
8.4.2. Veterinary Clinics Market Forecast and Analysis
8.5. PHARMACIES AND DRUG STORES
8.5.1. Overview
8.5.2. Pharmacies and Drug Stores Market Forecast and Analysis
9. COMPANION ANIMAL SPECIALTY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Companion Animal Specialty Drugs Market Overview
9.1.2 North America Companion Animal Specialty Drugs Market Forecasts and Analysis
9.1.3 North America Companion Animal Specialty Drugs Market Forecasts and Analysis - By Product Type
9.1.4 North America Companion Animal Specialty Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Companion Animal Specialty Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Companion Animal Specialty Drugs Market
9.1.5.1.1 United States Companion Animal Specialty Drugs Market by Product Type
9.1.5.1.2 United States Companion Animal Specialty Drugs Market by Distribution Channel
9.1.5.2 Canada Companion Animal Specialty Drugs Market
9.1.5.2.1 Canada Companion Animal Specialty Drugs Market by Product Type
9.1.5.2.2 Canada Companion Animal Specialty Drugs Market by Distribution Channel
9.1.5.3 Mexico Companion Animal Specialty Drugs Market
9.1.5.3.1 Mexico Companion Animal Specialty Drugs Market by Product Type
9.1.5.3.2 Mexico Companion Animal Specialty Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Companion Animal Specialty Drugs Market Overview
9.2.2 Europe Companion Animal Specialty Drugs Market Forecasts and Analysis
9.2.3 Europe Companion Animal Specialty Drugs Market Forecasts and Analysis - By Product Type
9.2.4 Europe Companion Animal Specialty Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Companion Animal Specialty Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Companion Animal Specialty Drugs Market
9.2.5.1.1 Germany Companion Animal Specialty Drugs Market by Product Type
9.2.5.1.2 Germany Companion Animal Specialty Drugs Market by Distribution Channel
9.2.5.2 France Companion Animal Specialty Drugs Market
9.2.5.2.1 France Companion Animal Specialty Drugs Market by Product Type
9.2.5.2.2 France Companion Animal Specialty Drugs Market by Distribution Channel
9.2.5.3 Italy Companion Animal Specialty Drugs Market
9.2.5.3.1 Italy Companion Animal Specialty Drugs Market by Product Type
9.2.5.3.2 Italy Companion Animal Specialty Drugs Market by Distribution Channel
9.2.5.4 Spain Companion Animal Specialty Drugs Market
9.2.5.4.1 Spain Companion Animal Specialty Drugs Market by Product Type
9.2.5.4.2 Spain Companion Animal Specialty Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Companion Animal Specialty Drugs Market
9.2.5.5.1 United Kingdom Companion Animal Specialty Drugs Market by Product Type
9.2.5.5.2 United Kingdom Companion Animal Specialty Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Companion Animal Specialty Drugs Market Overview
9.3.2 Asia-Pacific Companion Animal Specialty Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Companion Animal Specialty Drugs Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Companion Animal Specialty Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Companion Animal Specialty Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Companion Animal Specialty Drugs Market
9.3.5.1.1 Australia Companion Animal Specialty Drugs Market by Product Type
9.3.5.1.2 Australia Companion Animal Specialty Drugs Market by Distribution Channel
9.3.5.2 China Companion Animal Specialty Drugs Market
9.3.5.2.1 China Companion Animal Specialty Drugs Market by Product Type
9.3.5.2.2 China Companion Animal Specialty Drugs Market by Distribution Channel
9.3.5.3 India Companion Animal Specialty Drugs Market
9.3.5.3.1 India Companion Animal Specialty Drugs Market by Product Type
9.3.5.3.2 India Companion Animal Specialty Drugs Market by Distribution Channel
9.3.5.4 Japan Companion Animal Specialty Drugs Market
9.3.5.4.1 Japan Companion Animal Specialty Drugs Market by Product Type
9.3.5.4.2 Japan Companion Animal Specialty Drugs Market by Distribution Channel
9.3.5.5 South Korea Companion Animal Specialty Drugs Market
9.3.5.5.1 South Korea Companion Animal Specialty Drugs Market by Product Type
9.3.5.5.2 South Korea Companion Animal Specialty Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Companion Animal Specialty Drugs Market Overview
9.4.2 Middle East and Africa Companion Animal Specialty Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Companion Animal Specialty Drugs Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Companion Animal Specialty Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Companion Animal Specialty Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Companion Animal Specialty Drugs Market
9.4.5.1.1 South Africa Companion Animal Specialty Drugs Market by Product Type
9.4.5.1.2 South Africa Companion Animal Specialty Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Companion Animal Specialty Drugs Market
9.4.5.2.1 Saudi Arabia Companion Animal Specialty Drugs Market by Product Type
9.4.5.2.2 Saudi Arabia Companion Animal Specialty Drugs Market by Distribution Channel
9.4.5.3 U.A.E Companion Animal Specialty Drugs Market
9.4.5.3.1 U.A.E Companion Animal Specialty Drugs Market by Product Type
9.4.5.3.2 U.A.E Companion Animal Specialty Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Companion Animal Specialty Drugs Market Overview
9.5.2 South and Central America Companion Animal Specialty Drugs Market Forecasts and Analysis
9.5.3 South and Central America Companion Animal Specialty Drugs Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Companion Animal Specialty Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Companion Animal Specialty Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Companion Animal Specialty Drugs Market
9.5.5.1.1 Brazil Companion Animal Specialty Drugs Market by Product Type
9.5.5.1.2 Brazil Companion Animal Specialty Drugs Market by Distribution Channel
9.5.5.2 Argentina Companion Animal Specialty Drugs Market
9.5.5.2.1 Argentina Companion Animal Specialty Drugs Market by Product Type
9.5.5.2.2 Argentina Companion Animal Specialty Drugs Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. COMPANION ANIMAL SPECIALTY DRUGS MARKET, KEY COMPANY PROFILES
11.1. BAYER AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. INTERVET INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ZOETIS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELANCO
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVARTIS AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ARATANA THERAPEUTICS, INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BEAPHAR
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VIRBAC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CEVA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Bayer AG
- Intervet Inc
- Zoetis
- Elanco
- Boehringer Ingelheim International GmbH
- Novartis AG
- Aratana Therapeutics, Inc.
- Beaphar
- Virbac
- Ceva